Clinical Trial Update: The Effect of Brief Potent Glutamatergic Modulation on Cocaine Dependence [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on brief potent glutamatergic modulation for cocaine dependence; phases 1 and 2 terminated with posted results in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cocaine Dependence

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Cocaine Dependence | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2018-09-14